The TCL1A Oncoprotein Interacts Directly with the NF-κB Inhibitor IκB

Virginie Ropars, Gilles Despouy, Marc-Henri Stern et al. · 2009

Read The TCL1A Oncoprotein Interacts Directly with the NF-κB Inhibitor IκB by Virginie Ropars, Gilles Despouy, Marc-Henri Stern et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0006567.txt.

Description

Virginie Ropars, Gilles Despouy, Marc-Henri Stern, and colleagues studied a cancer protein's binding in PLOS ONE in 2009. The TCL1A oncoprotein plays key roles in several B and T cell malignancies. Lacking enzymatic activity, TCL1A's transforming action was linked to its partners. The team examined its interaction with IkB, the inhibitor of NF-kB.

Their title reports that TCL1A interacts directly with the NF-kB inhibitor. Binding the inhibitor could free NF-kB, a powerful survival signal for blood cells. That would explain how TCL1A drives leukemia without being an enzyme. The direct interaction gives drug designers a defined interface to target.

Catalog record

CREATORVirginie Ropars, Gilles Despouy, Marc-Henri Stern et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE29 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0006567

Browse the full library · About the Tower of Babel